4-ethoxy-2-pyridin-3-yl-N-[3-(1H-1,2,4-triazol-5-yl)propyl]quinoline-7-carboxamide
C22H22N6O2 — CID 122431451
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-ethoxy-2-pyridin-3-yl-N-[3-(1H-1,2,4-triazol-5-yl)propyl]quinoline-7-carboxamide
4-ethoxy-2-pyridin-3-yl-N-[3-(1H-1,2,4-triazol-5-yl)propyl]quinoline-7-carboxamide (PubChem CID 122431451) has the molecular formula C22H22N6O2 and a molecular weight of 402.46 g/mol. Its IUPAC name is 4-ethoxy-2-pyridin-3-yl-N-[3-(1H-1,2,4-triazol-5-yl)propyl]quinoline-7-carboxamide.
Molecular Properties
| Compound Name | 4-ethoxy-2-pyridin-3-yl-N-[3-(1H-1,2,4-triazol-5-yl)propyl]quinoline-7-carboxamide |
|---|---|
| PubChem CID | 122431451 |
| Molecular Formula | C22H22N6O2 |
| Molecular Weight | 402.46 g/mol |
| Exact Mass | 402.18 |
| IUPAC Name | 4-ethoxy-2-pyridin-3-yl-N-[3-(1H-1,2,4-triazol-5-yl)propyl]quinoline-7-carboxamide |
| SMILES | CCOc1cc(-c2cccnc2)nc2cc(C(=O)NCCCc3ncn[nH]3)ccc12 |
| InChI | InChI=1S/C22H22N6O2/c1-2-30-20-12-18(16-5-3-9-23-13-16)27-19-11-15(7-8-17(19)20)22(29)24-10-4-6-21-25-14-26-28-21/h3,5,7-9,11-14H,2,4,6,10H2,1H3,(H,24,29)(H,25,26,28) |
| InChIKey | CSLFWHRFMOIILE-UHFFFAOYSA-N |
| XLogP | 3.18 |
| TPSA | 105.68 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 402.46 |
| LogP ≤ 5 | 3.18 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122431451 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.